Logo image of SPAI

SAFE PRO GROUP INC (SPAI) Stock Fundamental Analysis

NASDAQ:SPAI - Nasdaq - US78642D1019 - Common Stock

3.67  +0.24 (+7%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SPAI. SPAI was compared to 65 industry peers in the Aerospace & Defense industry. The financial health of SPAI is average, but there are quite some concerns on its profitability. SPAI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SPAI had negative earnings in the past year.
SPAI Yearly Net Income VS EBIT VS OCF VS FCFSPAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 -2M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -225.67%, SPAI is doing worse than 96.88% of the companies in the same industry.
The Return On Equity of SPAI (-291.90%) is worse than 81.25% of its industry peers.
Industry RankSector Rank
ROA -225.67%
ROE -291.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPAI Yearly ROA, ROE, ROICSPAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 -100 -200 -300

1.3 Margins

SPAI has a better Gross Margin (34.43%) than 78.13% of its industry peers.
The Profit Margin and Operating Margin are not available for SPAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPAI Yearly Profit, Operating, Gross MarginsSPAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 -200 -400 -600

More info and screens

6

2. Health

2.1 Basic Checks

SPAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SPAI remains at a similar level compared to 1 year ago.
Compared to 1 year ago, SPAI has a worse debt to assets ratio.
SPAI Yearly Shares OutstandingSPAI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M 8M 10M
SPAI Yearly Total Debt VS Total AssetsSPAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 1M 2M 3M 4M

2.2 Solvency

An Altman-Z score of 13.14 indicates that SPAI is not in any danger for bankruptcy at the moment.
SPAI's Altman-Z score of 13.14 is amongst the best of the industry. SPAI outperforms 95.31% of its industry peers.
SPAI has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, SPAI belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 13.14
ROIC/WACCN/A
WACC10.19%
SPAI Yearly LT Debt VS Equity VS FCFSPAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 1M -1M 2M -2M

2.3 Liquidity

A Current Ratio of 3.19 indicates that SPAI has no problem at all paying its short term obligations.
SPAI's Current ratio of 3.19 is fine compared to the rest of the industry. SPAI outperforms 75.00% of its industry peers.
A Quick Ratio of 2.83 indicates that SPAI has no problem at all paying its short term obligations.
The Quick ratio of SPAI (2.83) is better than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 2.83
SPAI Yearly Current Assets VS Current LiabilitesSPAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

SPAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1143.76%.
The Revenue for SPAI has decreased by -20.24% in the past year. This is quite bad
EPS 1Y (TTM)-1143.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-20.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPAI Yearly Revenue VS EstimatesSPAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 200K 400K 600K 800K 1M
SPAI Yearly EPS VS EstimatesSPAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SPAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPAI Price Earnings VS Forward Price EarningsSPAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPAI Per share dataSPAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SPAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFE PRO GROUP INC

NASDAQ:SPAI (1/22/2025, 11:33:19 AM)

3.67

+0.24 (+7%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change0%
Ins Owners62.59%
Ins Owner Change-3.41%
Market Cap50.50M
AnalystsN/A
Price TargetN/A
Short Float %3.77%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22.96
P/FCF N/A
P/OCF N/A
P/B 11.93
P/tB 19.72
EV/EBITDA N/A
EPS(TTM)-0.97
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.16
BVpS0.31
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -225.67%
ROE -291.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.43%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.19
Quick Ratio 2.83
Altman-Z 13.14
F-ScoreN/A
WACC10.19%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1143.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1154.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-293.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-285.7%
OCF growth 3YN/A
OCF growth 5YN/A